(Q38006726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

4

Louise M Burrell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Josephine A Grace

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Kai Yan Mak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Peter W Angus

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

225-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Aliskiren combined with losartan in type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Review article: pancreatic renin-angiotensin systems in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Physiology of local renin-angiotensin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Characterization of the renin-aldosterone system in decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Inflammation and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Proinflammatory actions of angiotensins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin II and renal fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The renin angiotensin system and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Renin, (pro)renin and receptor: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The identification of a calmodulin-binding domain within the cytoplasmic tail of angiotensin-converting enzyme-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Human recombinant ACE2 reduces the progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Role of endothelin in systemic and portal resistance in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Vascular hyporesponsiveness to angiotensin II in rats with CCl(4)-induced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Role of PGI2 and effects of ACE inhibition on the bradykinin potentiation by angiotensin-(1-7) in resistance vessels of SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Renal failure in the patient with cirrhosis. The role of active vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Circulatory function and hepatorenal syndrome in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

Hepatorenal disorders: role of the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

The role of angiotensin(1-7) in renal vasculature of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120030

21 January 2018

Identifiers

DOI

10.1042/CS20120030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22548407%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference